Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease
- 31 October 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 146 (4) , 746
- https://doi.org/10.1016/s0002-8703(03)00391-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and InflammationHypertension, 2002
- Statins Modulate Oxidized Low-Density Lipoprotein-Mediated Adhesion Molecule Expression in Human Coronary Artery Endothelial Cells: Role of LOX-1The Journal of Pharmacology and Experimental Therapeutics, 2002
- Effect of isosorbide‐5‐mononitrate on plasma and urine levels of cyclic GMP in relation to exercise in coronary patients compared with control subjectsEuropean Journal of Clinical Investigation, 1995
- Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.Journal of Clinical Investigation, 1995
- Cell adhesion molecules in coronary artery diseaseJournal of the American College of Cardiology, 1994
- Local Transdermal Glyceryl Trinitrate Has an Antiinflammatory Action on Thrombophlebitis Induced by Sclerosis of Leg Varicose VeinsAngiology, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- The anti-inflammatory and analgesic action of transdermal glyceryltrinitrate in the treatment of infusion-related thrombophlebitisPostgraduate Medical Journal, 1993
- Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable anginaJournal of the American College of Cardiology, 1989
- Peripheral Atherosclerosis in Patients with Myocardial InfarctionAngiology, 1984